TrialThe Lancet. Infectious diseases2020

Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.

Firdausi Qadri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.